{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T12:08:38Z","timestamp":1788782918916,"version":"build-2803163510"},"reference-count":78,"publisher":"American Chemical Society (ACS)","issue":"9","license":[{"start":{"date-parts":[[2027,7,21]],"date-time":"2027-07-21T00:00:00Z","timestamp":1816128000000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100010429","name":"Erasmus MC Vriendenfonds","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100010429","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The gastrin-releasing peptide receptor (GRPR) is an attractive target for breast cancer (BC) imaging, but the in vivo performance of GRPR-targeted radioligands, such as RM2 and NeoB, is limited by metabolic instability, which may compromise tumor retention. Here, we designed two dimeric RM2-based radioligands, hdPP-01 and hdPP-02, to investigate whether homodimerization could improve the preclinical profile of GRPR-targeted radiotracers. hdPP-01 was synthesized using a 1,3,5-triazine core, whereas hdPP-02 was obtained via a 2-cyanobenzothiazole\/1,2-aminothiol click reaction. Both compounds were radiolabeled with indium-111 and evaluated in T47-D cells. The resulting radiotracers retained nanomolar GRPR-binding properties, showed higher GRPR-specific cellular uptake, and displayed improved stability in murine serum compared to [111In]In-RM2. In vivo, [111In]In-hdPP-01 demonstrated higher tumor uptake and prolonged retention time relative to [111In]In-RM2. These findings indicate that homodimerization can modulate stability, cellular uptake and tumor accumulation, supporting further optimization of dimeric RM2-based radioligands for GRPR-targeted BC imaging and therapy.<\/jats:p>","DOI":"10.1021\/acs.molpharmaceut.6c00242","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T16:05:16Z","timestamp":1784649916000},"page":"4553-4570","source":"Crossref","is-referenced-by-count":0,"title":["Design,\nSynthesis, and Preclinical Evaluation of Novel\nDimeric RM2-Based Radioligands for GRPR-Targeted Breast Cancer Imaging"],"prefix":"10.1021","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-3848-1917","authenticated-orcid":true,"given":"P.","family":"Parai\u0308so","sequence":"first","affiliation":[{"name":"Erasmus University Medical Center Rotterdam , , ,","place":["Rotterdam, The Netherlands, 3015 GD"]},{"name":"Erasmus MC Cancer Institute , Erasmus University Medical Center Rotterdam, ,","place":["Rotterdam, The Netherlands, 3015 GD"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Savanovic","sequence":"additional","affiliation":[{"name":"Erasmus University Medical Center Rotterdam , , ,","place":["Rotterdam, The Netherlands, 3015 GD"]},{"name":"Erasmus MC Cancer Institute , Erasmus University Medical Center Rotterdam, ,","place":["Rotterdam, The Netherlands, 3015 GD"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Li","sequence":"additional","affiliation":[{"name":"Erasmus University Medical Center Rotterdam , , ,","place":["Rotterdam, The Netherlands, 3015 GD"]},{"name":"Erasmus MC Cancer Institute , Erasmus University Medical Center Rotterdam, ,","place":["Rotterdam, The Netherlands, 3015 GD"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7307-0388","authenticated-orcid":true,"given":"H.","family":"Ma","sequence":"additional","affiliation":[{"name":"Erasmus University Medical Center Rotterdam , , ,","place":["Rotterdam, The Netherlands, 3015 GD"]},{"name":"Erasmus MC Cancer Institute , Erasmus University Medical Center Rotterdam, ,","place":["Rotterdam, The Netherlands, 3015 GD"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"de Ridder","sequence":"additional","affiliation":[{"name":"Erasmus University Medical Center Rotterdam , , ,","place":["Rotterdam, The Netherlands, 3015 GD"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Stuurman","sequence":"additional","affiliation":[{"name":"Erasmus University Medical Center Rotterdam , , ,","place":["Rotterdam, The Netherlands, 3015 GD"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.H.M.","family":"van Deurzen","sequence":"additional","affiliation":[{"name":"Erasmus MC Cancer Institute , Erasmus University Medical Center Rotterdam, ,","place":["Rotterdam, The Netherlands, 3015 GD"]},{"name":"Erasmus University Medical Center , , ,","place":["Rotterdam, The Netherlands, 3015 GD"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9736-5318","authenticated-orcid":true,"given":"Y.","family":"Seimbille","sequence":"additional","affiliation":[{"name":"Erasmus University Medical Center Rotterdam , , ,","place":["Rotterdam, The Netherlands, 3015 GD"]},{"name":"Erasmus MC Cancer Institute , Erasmus University Medical Center Rotterdam, ,","place":["Rotterdam, The Netherlands, 3015 GD"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"2026090707082309000_cit1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics\n2020: GLOBOCAN estimates of incidence and mortality worldwide for\n36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin"},{"key":"2026090707082309000_cit2","doi-asserted-by":"publisher","first-page":"R337","DOI":"10.1530\/ERC-16-0121","article-title":"Endocrine resistance\nin hormone-responsive breast cancer:\nmechanisms and therapeutic strategies","volume":"23","author":"Murphy","year":"2016","journal-title":"Endocr\nRelat Cancer"},{"key":"2026090707082309000_cit3","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","article-title":"Effects of chemotherapy\nand hormonal therapy for early breast cancer\non recurrence and 15-year survival: an overview of the randomised\ntrials","volume":"365","year":"2005","journal-title":"Lancet"},{"key":"2026090707082309000_cit4","doi-asserted-by":"publisher","first-page":"4951","DOI":"10.1158\/0008-5472.CAN-09-0099","article-title":"Breast cancer metastasis:\nchallenges and opportunities","volume":"69","author":"Lu","year":"2009","journal-title":"Cancer Res."},{"key":"2026090707082309000_cit5","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1053\/j.semnuclmed.2024.01.004","article-title":"Gastrin-releasing\npeptide receptor as a theranostic target in breast cancer: a systematic\nscoping review","volume":"54","author":"Baun","year":"2024","journal-title":"Semin Nucl. Med."},{"key":"2026090707082309000_cit6","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.7150\/thno.14958","article-title":"Gastrin-releasing Peptide\nReceptor Imaging in Breast Cancer Using the Receptor Antagonist (68)Ga-RM2\nAnd PET","volume":"6","author":"Stoykow","year":"2016","journal-title":"Theranostics"},{"key":"2026090707082309000_cit7","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.2967\/jnumed.116.188011","article-title":"Expression of Gastrin-Releasing\nPeptide Receptor in Breast Cancer and Its Association with Pathologic,\nBiologic, and Clinical Parameters: A Study of 1,432 Primary Tumors","volume":"58","author":"Morgat","year":"2017","journal-title":"J. Nucl. Med."},{"key":"2026090707082309000_cit8","doi-asserted-by":"publisher","first-page":"1250799","DOI":"10.3389\/fmed.2023.1250799","article-title":"GRPR-targeting\nradiotheranostics for breast cancer management","volume":"10","author":"D\u2019Onofrio","year":"2023","journal-title":"Front Med. (Lausanne)"},{"key":"2026090707082309000_cit9","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1097\/MED.0b013e32831cf5aa","article-title":"Regulation\nand signaling of human bombesin receptors and their biological effects","volume":"16","author":"Weber","year":"2009","journal-title":"Curr. Opin Endocrinol Diabetes Obes"},{"key":"2026090707082309000_cit10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/pr.107.07108","article-title":"International union\nof pharmacology. LXVIII. Mammalian bombesin receptors: Nomenclature,\ndistribution, pharmacology, signaling, and functions in normal and\ndisease states","volume":"60","author":"Jensen","year":"2008","journal-title":"Pharmacol Rev."},{"key":"2026090707082309000_cit11","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1016\/0016-5085(93)91062-M","article-title":"Expression of bombesin-receptor\nsubtypes and their\ndifferential regulation of colonic smooth muscle contraction","volume":"105","author":"Bitar","year":"1993","journal-title":"Gastroenterology"},{"key":"2026090707082309000_cit12","first-page":"1035","article-title":"Inhibitory\neffect of bombesin receptor antagonist RC-3095 on the growth of human\npancreatic cancer cells in vivo and in vitro","volume":"54","author":"Qin","year":"1994","journal-title":"Cancer Res."},{"key":"2026090707082309000_cit13","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1093\/annonc\/mdm058","article-title":"Gastrin-releasing peptide receptor\nas a molecular target in experimental anticancer therapy","volume":"18","author":"Cornelio","year":"2007","journal-title":"Ann. Oncol"},{"key":"2026090707082309000_cit14","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1038\/bjc.1995.210","article-title":"High-affinity\nbinding sites for gastrin-releasing peptide on human colorectal cancer\ntissue but not uninvolved mucosa","volume":"71","author":"Preston","year":"1995","journal-title":"Br. J. Cancer"},{"key":"2026090707082309000_cit15","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1016\/S0002-9440(10)65525-3","article-title":"Gastrin-releasing\npeptide receptors in non-neoplastic\nand neoplastic human breast","volume":"155","author":"Gugger","year":"1999","journal-title":"Am. J. Pathol."},{"key":"2026090707082309000_cit16","first-page":"1152","article-title":"Gastrin-releasing\npeptide receptors in the human prostate:\nRelation to neoplastic transformation","volume":"59","author":"Markwalder","year":"1999","journal-title":"Cancer\nRes."},{"key":"2026090707082309000_cit17","volume-title":"Radionuclide-based\npharmaceuticals for breast cancer imaging: state of the art","author":"Parai\u0308so","year":"2026"},{"key":"2026090707082309000_cit18","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.2967\/jnumed.120.259630","article-title":"Results from 50 patients\nwith biochemically recurrent prostate cancer","volume":"62","author":"Baratto","year":"2021","journal-title":"J. Nucl. Med."},{"key":"2026090707082309000_cit19","first-page":"79","article-title":"Molecular imaging of bombesin receptors\nin various tumors by Ga-68 AMBA PET\/CT: First results","volume":"48","author":"Baum","year":"2007","journal-title":"J. Nucl. Med."},{"key":"2026090707082309000_cit20","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1089\/108497804323072002","article-title":"Gastrin-releasing\npeptide (GRP) analogues for cancer\nimaging","volume":"19","author":"Varvarigou","year":"2004","journal-title":"Cancer Biother Radiopharm"},{"key":"2026090707082309000_cit21","doi-asserted-by":"publisher","first-page":"5434","DOI":"10.1158\/1078-0432.CCR-12-3490","article-title":"In vivo imaging of prostate\ncancer using [68Ga]-labeled bombesin analog BAY86\u20137548","volume":"19","author":"Ka\u0308hkonen","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"2026090707082309000_cit22","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.2967\/jnumed.112.118695","article-title":"99mTc radiotracers\nbased on human GRP (18\u201327):\nSynthesis and comparative evaluation","volume":"54","author":"Marsouvanidis","year":"2013","journal-title":"J. Nucl.\nMed."},{"key":"2026090707082309000_cit23","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.7150\/thno.14958","article-title":"Gastrin-releasing peptide\nreceptor imaging in breast cancer using the receptor antagonist 68Ga-RM2\nand PET","volume":"6","author":"Stoykow","year":"2016","journal-title":"Theranostics"},{"key":"2026090707082309000_cit24","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2967\/jnumed.116.178889","article-title":"Theranostic perspectives\nin prostate cancer with the gastrin-releasing peptide receptor antagonist\nNeoBOMB1: Preclinical and first clinical results","volume":"58","author":"Nock","year":"2017","journal-title":"J. Nucl. Med."},{"key":"2026090707082309000_cit25","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00259-019-04504-3","article-title":"First-in-human\ndosimetry of\u2500Gastrin- releasing\npeptide receptor antagonist [177Lu]Lu-RM2: A radiopharmaceutical for\nthe treatment of metastatic castration-resistant prostate cancer","volume":"47","author":"Kurth","year":"2020","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"2026090707082309000_cit26","doi-asserted-by":"publisher","first-page":"104","DOI":"10.7150\/thno.13580","article-title":"In vivo stabilization\nof a gastrin-releasing peptide receptor antagonist enhances PET imaging\nand radionuclide therapy of prostate cancer in preclinical studies","volume":"6","author":"Chatalic","year":"2016","journal-title":"Theranostics"},{"key":"2026090707082309000_cit27","doi-asserted-by":"publisher","first-page":"5240","DOI":"10.1158\/1078-0432.CCR-08-3145","article-title":"Evaluation of a 1, 4,\n7, 10-Tetraazacyclododecane-1, 4, 7, 10-Tetraacetic Acid\u2013Conjugated\nBombesin-Based Radioantagonist for the Labeling with Single- Photon\nEmission Computed Tomography, Positron Emission Tomography, and Therapeutic\nRadionuclides DOTA-Conjugated Bombesin Antagonist","volume":"15","author":"Mansi","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"2026090707082309000_cit28","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.3390\/molecules24162878","article-title":"Stability\nEvaluation and Stabilization of a Gastrin-Releasing Peptide Receptor\n(GRPR) Targeting Imaging Pharmaceutical","volume":"24","author":"Ghosh","year":"2019","journal-title":"Molecules"},{"key":"2026090707082309000_cit29","first-page":"346","article-title":"Preliminary diagnostic\nperformance of [68Ga]-NeoBOMB1 in patients with gastrin-releasing\npeptide receptor-positive breast, prostate, colorectal or lung tumors\nNeofind","volume":"61","author":"Djaileb","year":"2020","journal-title":"J. Nucl. Med."},{"key":"2026090707082309000_cit30","doi-asserted-by":"publisher","first-page":"4440","DOI":"10.1007\/s00259-022-05926-2","article-title":"Safety of [177Lu]Lu-NeoBOMB1\ntreatment: A preclinical study characterizing absorbed dose and acute,\nearly, and late organ toxicity","volume":"49","author":"Ruigrok","year":"2022","journal-title":"Eur. J. Nucl.\nMed. Mol. Imaging"},{"key":"2026090707082309000_cit31","article-title":"A Phase I\/IIa Open-label, Multi-center Study to Evaluate\nthe Safety,\nTolerability, Whole-body Distribution","year":"2019","journal-title":"Radiation\nDosimetry and Anti-tumor Activity of [177Lu]-NeoB Administered in\nPatients With Advanced Solid Tumors Known to Overexpress Gastrin-releasing\nPeptide Receptor (GRPR)"},{"key":"2026090707082309000_cit32","doi-asserted-by":"publisher","first-page":"262","DOI":"10.2967\/jnumed.125.270411","article-title":"Phase 1 Study of [(177)Lu]Lu-NeoB\nin Patients with Advanced Solid Tumors Overexpressing Gastrin-Releasing\nPeptide Receptor: Preliminary Safety and Dosimetry Results","volume":"67","author":"Mittra","year":"2025","journal-title":"J. Nucl. Med."},{"key":"2026090707082309000_cit33","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.1007\/s00259-023-06364-4","article-title":"Side-by-side comparison\nof the two widely studied GRPR-radiotracers,\nradiolabeled NeoB and RM2, in a preclinical setting","volume":"50","author":"Damiana","year":"2023","journal-title":"European journal of nuclear medicine and molecular imaging"},{"key":"2026090707082309000_cit34","doi-asserted-by":"publisher","first-page":"6521","DOI":"10.1074\/jbc.M209764200","article-title":"Sequence identification\nand characterization\nof human carnosinase and a closely related non- specific dipeptidase","volume":"278","author":"Teufel","year":"2003","journal-title":"J. Biol. Chem."},{"key":"2026090707082309000_cit35","doi-asserted-by":"publisher","first-page":"6707","DOI":"10.1158\/0008-5472.CAN-03-3845","article-title":"Synthesis and evaluation\nof bombesin derivatives on the basis of pan-bombesin peptides labeled\nwith indium-111, lutetium-177, and yttrium-90 for targeting bombesin\nreceptor- expressing tumors","volume":"64","author":"Zhang","year":"2004","journal-title":"Cancer Res."},{"key":"2026090707082309000_cit36","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2967\/jnumed.113.129411","article-title":"To serve and protect\u201d:\nEnzyme inhibitors as radiopeptide escorts promote tumor targeting","volume":"55","author":"Nock","year":"2014","journal-title":"J. Nucl. Med."},{"key":"2026090707082309000_cit37","doi-asserted-by":"publisher","first-page":"10662","DOI":"10.1073\/pnas.88.23.10662","article-title":"CD10\/neutral endopeptidase\n24.11 hydrolyzes bombesin-like\npeptides and regulates the growth of small cell carcinomas of the\nlung","volume":"88","author":"Shipp","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2026090707082309000_cit38","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1021\/bc9000189","article-title":"In vitro and in vivo\nmetabolism of Lu-AMBA, a GRP-receptor binding compound, and the synthesis\nand characterization of its metabolites","volume":"20","author":"Linder","year":"2009","journal-title":"Bioconjug\nChem."},{"key":"2026090707082309000_cit39","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1021\/bc800157h","article-title":"Synthesis,\n18F-labeling, and in vitro and in vivo studies of bombesin peptides\nmodified with silicon-based building blocks","volume":"19","author":"Hohne","year":"2008","journal-title":"Bioconjug Chem."},{"key":"2026090707082309000_cit40","doi-asserted-by":"publisher","first-page":"867","DOI":"10.2967\/jnumed.112.114082","article-title":"Plasma\npharmacokinetics, whole-body distribution, metabolism, and radiation\ndosimetry of 68Ga bombesin antagonist BAY 86\u20137548 in healthy\nmen","volume":"54","author":"Roivainen","year":"2013","journal-title":"J. Nucl. Med."},{"key":"2026090707082309000_cit41","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1021\/jo011148j","article-title":"Peptidotriazoles on solid phase:\n[1,2,3]-triazoles by regiospecific copper(i)-catalyzed 1,3-dipolar\ncycloadditions of terminal alkynes to azides","volume":"67","author":"Torn\u00f8e","year":"2002","journal-title":"Journal of organic chemistry"},{"key":"2026090707082309000_cit42","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1002\/1521-3773(20020715)41:14&lt;2596::AID-ANIE2596&gt;3.0.CO;2-4","article-title":"A stepwise\nhuisgen cycloaddition process: copper(I)-catalyzed regioselective\n\u201cligation\u201d of azides and terminal alkynes","volume":"41","author":"Rostovtsev","year":"2002","journal-title":"Angew. Chem."},{"key":"2026090707082309000_cit43","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1021\/cr0783479","article-title":"Cu-catalyzed\nazide-alkyne cycloaddition","volume":"108","author":"Meldal","year":"2008","journal-title":"Chem. Rev."},{"key":"2026090707082309000_cit44","doi-asserted-by":"publisher","first-page":"6134","DOI":"10.1039\/D0OB01222J","article-title":"A Novel Clickable\nMSAP Agent for Dual Fluorescence\/Nuclear Labeling of Biovectors","volume":"18","author":"Chen","year":"2020","journal-title":"Organic & Biomolecular Chemistry"},{"key":"2026090707082309000_cit45","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/molecules24010023","article-title":"A Flexible\nSynthesis of 68Ga-Labeled Carbonic Anhydrase IX (CAIX)-Targeted Molecules\nvia CBT\/1,2-Aminothiol Click Reaction","volume":"24","author":"Chen","year":"2019","journal-title":"Molecules"},{"key":"2026090707082309000_cit46","doi-asserted-by":"publisher","first-page":"6134","DOI":"10.1039\/D0OB01222J","article-title":"A novel clickable\nMSAP agent for dual fluorescence\/nuclear labeling of biovectors","volume":"18","author":"Chen","year":"2020","journal-title":"Organic & biomolecular chemistry"},{"key":"2026090707082309000_cit47","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1002\/psc.3222","article-title":"Improving\nthe aqueous solubility of HCV-E2 glycoprotein epitope mimics by cyclization\nusing POLAR hinges","volume":"26","author":"Meuleman","year":"2020","journal-title":"Journal of peptide science:\nan official publication of the European Peptide Society"},{"key":"2026090707082309000_cit48","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/jlcr.3190","article-title":"Synthesis of a non-peptidic PET tracer\ndesigned for \u03b15\u03b21 integrin receptor","volume":"57","author":"Monaco","year":"2014","journal-title":"Journal of labelled compounds & radiopharmaceuticals."},{"key":"2026090707082309000_cit49","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3390\/pharmaceutics15020481","article-title":"A Theranostic Small-Molecule\nProdrug Conjugate for Neuroendocrine Prostate Cancer","volume":"15","author":"Gonzalez","year":"2023","journal-title":"Pharmaceutics"},{"key":"2026090707082309000_cit50","doi-asserted-by":"publisher","first-page":"752","DOI":"10.2967\/jnumed.114.153023","article-title":"In Vitro and in vivo\napplication of radiolabeled gastrin releasing peptide receptor ligands\nin breast cancer","volume":"56","author":"Dalm","year":"2015","journal-title":"J. Nucl. Med."},{"key":"2026090707082309000_cit51","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.xphs.2015.11.015","article-title":"PEGylation of Biopharmaceuticals:\nA Review of Chemistry and Nonclinical Safety Information of Approved\nDrugs","volume":"105","author":"Turecek","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"2026090707082309000_cit52","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a\nStrategy for Improving Nanoparticle-Based Drug and Gene Delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv. Drug Deliv Rev."},{"key":"2026090707082309000_cit53","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.2174\/1568026611212230005","article-title":"Effectiveness of quenchers to reduce\nradiolysis of (111)In- or (177)Lu-labelled methionine-containing regulatory\npeptides. Maintaining radiochemical purity as measured by HPLC","volume":"12","author":"de Blois","year":"2013","journal-title":"Curr. Top Med. Chem."},{"key":"2026090707082309000_cit54","doi-asserted-by":"publisher","first-page":"13148","DOI":"10.3390\/molecules181113148","article-title":"Peptide conjugation via CuAAC \u201cclick\u201d chemistry","volume":"18","author":"Ahmad Fuaad","year":"2013","journal-title":"Molecules"},{"key":"2026090707082309000_cit55","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1021\/acs.bioconjchem.6b00267","article-title":"Extent of the Oxidative\nSide Reactions to Peptides\nand Proteins During the CuAAC Reaction","volume":"27","author":"Li","year":"2016","journal-title":"Bioconjugate\nChem."},{"key":"2026090707082309000_cit56","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.1039\/c0cc05376g","article-title":"Anaerobic conditions to reduce oxidation of proteins\nand to accelerate the copper-catalyzed \u201cClick\u201d reaction\nwith a water-soluble bis(triazole) ligand","volume":"47","author":"Kumar","year":"2011","journal-title":"Chem.\nCommun. (Camb)"},{"key":"2026090707082309000_cit57","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1021\/bc100272z","article-title":"Labeling live cells\nby copper-catalyzed alkyne--azide click chemistry","volume":"21","author":"Hong","year":"2010","journal-title":"Bioconjug Chem."},{"key":"2026090707082309000_cit58","doi-asserted-by":"publisher","first-page":"9879","DOI":"10.1002\/anie.200905087","article-title":"Analysis and Optimization\nof Copper-Catalyzed Azide\u2013Alkyne Cycloaddition for Bioconjugation","volume":"48","author":"Hong","year":"2009","journal-title":"Angew. Chem., Int. Ed."},{"key":"2026090707082309000_cit59","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1021\/acs.bioconjchem.5b00665","article-title":"Measuring and Suppressing the Oxidative Damage to DNA During Cu(I)-Catalyzed\nAzide\u2013Alkyne Cycloaddition","volume":"27","author":"Abel","year":"2016","journal-title":"Bioconjugate\nChem."},{"key":"2026090707082309000_cit60","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1021\/acs.bioconjchem.3c00286","article-title":"Click Chemistry\nand Radiochemistry: An Update","volume":"34","author":"Bauer","year":"2023","journal-title":"Bioconjugate\nChem."},{"key":"2026090707082309000_cit61","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1021\/ml300236m","article-title":"Strain-Promoted Catalyst-Free\nClick Chemistry for Rapid Construction of (64)Cu-Labeled PET Imaging\nProbes","volume":"3","author":"Chen","year":"2012","journal-title":"ACS medicinal chemistry letters"},{"key":"2026090707082309000_cit62","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/jlcr.3165","article-title":"Chelators for copper\nradionuclides in positron emission\ntomography radiopharmaceuticals","volume":"57","author":"Cai","year":"2014","journal-title":"Journal of\nlabelled compounds & radiopharmaceuticals."},{"key":"2026090707082309000_cit63","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.3390\/molecules28041884","article-title":"Radiolysis-Associated\nDecrease in Radiochemical Purity of 177Lu-Radiopharmaceuticals and\nComparison of the Effectiveness of Selected Quenchers against This\nProcess","volume":"28","author":"Larenkov","year":"2023","journal-title":"Molecules"},{"key":"2026090707082309000_cit64","doi-asserted-by":"publisher","first-page":"20536","DOI":"10.3390\/molecules191220536","article-title":"18F-Labeled Peptides: The Future\nIs Bright","volume":"19","author":"Richter","year":"2014","journal-title":"Molecules"},{"key":"2026090707082309000_cit65","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/ph11010030","article-title":"Comparison Study of\nTwo Differently Clicked (18)F-Folates-Lipophilicity Plays a Key Role","volume":"11","author":"Kettenbach","year":"2018","journal-title":"Pharmaceuticals (Basel)"},{"key":"2026090707082309000_cit66","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41392-022-00904-4","article-title":"Therapeutic peptides:\ncurrent applications and future directions","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"2026090707082309000_cit67","doi-asserted-by":"publisher","first-page":"114904","DOI":"10.1016\/j.addr.2023.114904","article-title":"Strategies for overcoming protein and peptide instability\nin biodegradable drug delivery systems","volume":"199","author":"Shi","year":"2023","journal-title":"Adv.\nDrug Deliv Rev."},{"key":"2026090707082309000_cit68","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1089\/cbr.2016.2136","article-title":"In Vitro Mouse and\nHuman Serum Stability of a Heterobivalent Dual-Target Probe That Has\nStrong Affinity to Gastrin-Releasing Peptide and Neuropeptide Y1 Receptors\non Tumor Cells","volume":"32","author":"Ghosh","year":"2017","journal-title":"Cancer Biother Radiopharm"},{"key":"2026090707082309000_cit69","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.3390\/molecules24162878","article-title":"Stability\nEvaluation and Stabilization of a Gastrin-Releasing Peptide Receptor\n(GRPR) Targeting Imaging Pharmaceutical","volume":"24","author":"Ghosh","year":"2019","journal-title":"Molecules"},{"key":"2026090707082309000_cit70","doi-asserted-by":"publisher","first-page":"914","DOI":"10.2967\/jnumed.114.147413","article-title":"Preclinical Evaluation\nof a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker\nMoiety for Imaging and Endoradiotherapy of Prostate Cancer","volume":"56","author":"Benesova\u0301","year":"2015","journal-title":"J. Nucl. Med."},{"key":"2026090707082309000_cit71","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1021\/acs.bioconjchem.5b00687","article-title":"Novel Bispecific\nPSMA\/GRPr Targeting Radioligands with Optimized Pharmacokinetics for\nImproved PET Imaging of Prostate Cancer","volume":"27","author":"Liolios","year":"2016","journal-title":"Bioconjugate\nChem."},{"issue":"24 Pt1","key":"2026090707082309000_cit72","first-page":"7022","article-title":"Mechanisms of Heterogeneous Distribution of Monoclonal\nAntibodies and Other Macromolecules in Tumors: Significance of Elevated\nInterstitial Pressure","volume":"48","author":"Jain","year":"1988","journal-title":"Cancer Res."},{"issue":"4","key":"2026090707082309000_cit73","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.nucmedbio.2014.01.001","article-title":"Synthesis and biological\nevaluation of copper-64 radiolabeled [DUPA-6-Ahx-(NODAGA)-5-Ava-BBN(7\u201314)NH2],\na novel bivalent targeting vector having affinity for two distinct\nbiomarkers (GRPr\/PSMA) of prostate cancer","volume":"41","author":"Bandari","year":"2014","journal-title":"Nuclear\nmedicine and biology"},{"key":"2026090707082309000_cit74","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1007\/s00259-006-0347-4","article-title":"DOTA-PESIN, a DOTA-conjugated\nbombesin derivative designed for the imaging and targeted radionuclide\ntreatment of bombesin receptor-positive tumours","volume":"34","author":"Zhang","year":"2007","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"2026090707082309000_cit75","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ymeth.2009.03.012","article-title":"Molecular imaging\ntargeting peptide receptors","volume":"48","author":"Schottelius","year":"2009","journal-title":"Methods (San Diego,\nCalif."},{"key":"2026090707082309000_cit76","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.2967\/jnumed.110.075101","article-title":"Renal toxicity of radiolabeled\npeptides and antibody fragments: mechanisms, impact on radionuclide\ntherapy, and strategies for prevention","volume":"51","author":"Vegt","year":"2010","journal-title":"Journal\nof nuclear medicine"},{"key":"2026090707082309000_cit77","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00259-002-0982-3","article-title":"Safe and\neffective inhibition of renal uptake of radiolabelled octreotide by\na combination of lysine and arginine","volume":"30","author":"Rolleman","year":"2003","journal-title":"European\njournal of nuclear medicine and molecular imaging"},{"key":"2026090707082309000_cit78","doi-asserted-by":"publisher","first-page":"675","DOI":"10.2967\/jnumed.115.170977","article-title":"Bombesin-Targeted\nPET of Prostate Cancer","volume":"57","author":"Mansi","year":"2016","journal-title":"Journal of nuclear medicine"}],"container-title":["Molecular Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.6c00242","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/23\/9\/4553\/66090269\/acs.molpharmaceut.6c00242.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/23\/9\/4553\/66090269\/acs.molpharmaceut.6c00242.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:21:18Z","timestamp":1788780078000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article\/23\/9\/4553\/5224829\/Design-Synthesis-and-Preclinical-Evaluation-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":78,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,7,21]]},"published-print":{"date-parts":[[2026,9,7]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.6c00242","relation":{},"ISSN":["1543-8384","1543-8392"],"issn-type":[{"value":"1543-8384","type":"print"},{"value":"1543-8392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]}}}